The purpose of this study was to determine if treatment with adjunctive galantamine is
effective in the reduction of functional impairments in patients with schizophrenia and
schizoaffective disorder. It was hypothesized that adjunctive galantamine would yield
clinically significant improvements from baseline to end of study on a measure of quality of
life and a measure of independent living skills.
Phase:
Phase 4
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research